Vision and Mission
Services
Team and Partners
For whom we work
News
Publications
Contact
Version imprimable de cet article Printable version

Pandemics Influenza A(H1N1): lessons to be drawn

18 March 2010

The pandemics pick in Switzerland is now behind us and, fortunately, the A(H1N1) virus has been rather mild. At present, we have to analyse objectively how the pandemics has been faced and managed by the Swiss federal and cantonal authorities, the health care personnel, the media, the pharmaceutical industry, etc..This will allow to improve the preparedness for similar or more severe future events. It will also be important to determine the fate of the pandemic virus A(H1N1): will it replace the past seasonal H1N1 virus, or will it undergo mutations affecting its virulence, or will it recombine with other influenza viruses, or simply will it disappear?
News
Appeal to the Swiss Federal Council for an innovative financing model for the research on new antimicrobials
26 November 2017

On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.

The text of the call of November 9, 2017 can be seen under "Publications"

The World Antibiotic Awareness Week will be held on 13-19 November 2017. Switzerland will participate.
8 November 2017

With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).

Additional information: StAR NRP72

FEMS 2017, the European microbiology congress, will be held in Valencia, Spain, July 9-13, 2017
29 December 2016

FEMS 2017, the 7th congress of FEMS (Federation of European Microbiological Societies) will be hosted by the Spanish Society for Microbiology (SEM). More than 2’000 participants from all over the world are expected in Valencia from July 9 to 13 to attend this event, which is offering 6 plenary lectures, 32 symposia, 24 workshops, poster discussion sessions, and several special events such as how to publish a paper, or from research to start-up creation, or education. All the domains of microbiology will be considered, including basic and applied research, environment and medical microbiology, microbial cell structure, genetics, antimicrobial resistance, mycology, virology, food microbiology, bioremediation, climate changes, etc..

Additional information: FEMS 2017

interlifescience   Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
ByteCode - informatique libre